financetom
Business
financetom
/
Business
/
Paramount chair Shari Redstone confirms thyroid cancer diagnosis
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Paramount chair Shari Redstone confirms thyroid cancer diagnosis
Jun 5, 2025 5:44 PM

June 5 (Reuters) - Paramount Global ( PARAA ) chair Shari Redstone was diagnosed with

thyroid cancer earlier this spring, a spokesperson for Redstone said in a statement to Reuters

on Thursday.

After experiencing fatigue and other symptoms, Redstone sought medical help about two months

ago and was diagnosed with thyroid cancer the next day. While surgeons removed her thyroid

gland, some cancer cells remained as they had spread to her vocal cords, according to the New

York Times, which first reported the news on Thursday.

"She is maintaining all professional and philanthropic activities throughout her treatment,

which is ongoing. She and her family are grateful that her prognosis is excellent," Redstone's

spokesperson Molly Morse said.

Redstone kept her diagnosis private, sharing it only with a tight circle of relatives, close

friends, and advisers including David Ellison, the Skydance head and tech heir, whose company is

set to purchase Paramount and the Redstone family's stake, NYT added.

The diagnosis comes against the backdrop of Paramount preparing for an $8.4 billion merger

with Skydance Media, which still requires U.S. FCC approval. The company also entered mediation

to try and settle a lawsuit by U.S. President Donald Trump against CBS, reportedly offering $15

million to settle.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck sees over $5 billion opportunity in Cidara's experimental flu drug
Merck sees over $5 billion opportunity in Cidara's experimental flu drug
Nov 17, 2025
By Mariam Sunny and Michael Erman Nov 17 (Reuters) - Merck ( MRK ) said on Monday it expects a commercial opportunity exceeding $5 billion from Cidara Therapeutics' ( CDTX ) experimental flu drug, and does not anticipate it to require a review by the U.S. CDC's vaccine advisory panel before launch. The U.S. drugmaker announced a nearly $9.2 billion...
Distribution Solutions Group Adds $30 Million to Buyback Plan
Distribution Solutions Group Adds $30 Million to Buyback Plan
Nov 17, 2025
09:43 AM EST, 11/17/2025 (MT Newswires) -- Distribution Solutions Group ( DSGR ) said Monday its board approved an additional $30 million for its share repurchase program. The company said the new authorization is on top of roughly $2.9 million that remains from earlier approvals. Shares of the company were up more than 3% in recent Monday trading. Price: 27.08,...
Kornit Digital Names New CFO, Approves $100 Million Share Buyback Plan; Shares Rise
Kornit Digital Names New CFO, Approves $100 Million Share Buyback Plan; Shares Rise
Nov 17, 2025
10:14 AM EST, 11/17/2025 (MT Newswires) -- Kornit Digital ( KRNT ) said Monday that Chief Financial Officer Lauri Hanover is stepping down from her position for personal reasons and the company has named Assaf Zipori as its new CFO. Hanover will stay as CFO through mid-December, the company said. Zipori most recently was global CFO of Nano Dimension (NNDM)...
France targets Vinted for failure to prevent underage access to adult content
France targets Vinted for failure to prevent underage access to adult content
Nov 17, 2025
PARIS, Nov 17 (Reuters) - France's child protection agency chief Sarah El Hairy has asked the regulator to investigate second-hand clothes marketplace Vinted for failing to prevent minors accessing adult content, in another move against e-commerce giants in the country. El Hairy asked TV and Internet regulator Arcom to probe Vinted after finding some classified ads on the platform allegedly...
Copyright 2023-2026 - www.financetom.com All Rights Reserved